FDA Requests More Information On Meda AB's New Azelastine Formulation
MEDA AB (publ) is an international specialty pharma company that concentrates on marketing and market-adapted product development. Acquisitions and long-term partnerships are fundamental factors that drive the company’s strategy. Meda is represented with own organisations in 26 countries and with more than 1 500 employees within marketing and sales. Meda’s products are sold in approximately 120 countries world-wide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit www.meda.se.
This information was brought to you by Cision http://newsroom.cision.com.
Contact: MEDA AB Investor Relations: Anders Larnholt, +46 8 630 19 62 / +46 709 458 878 anders.larnholt@meda.se
Source: Meda